AzTrials
AzTrials

Cervicogenic HeadacheNCT03583190

Cervical-Cranial Dry Needling vs. Orthopedic Manual Therapy for Cervicogenic Headache

A study testing Cervical-cranial dry needling, Orthopedic manual therapy and Thoracic Manipulation in people with Cervicogenic Headache, run by Youngstown State University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Dry needling is a therapeutic modality used to treat a number of neuromusculoskeletal conditions. Practice trends suggest it is becoming widely used by Physical Therapists to help patients manage symptoms associated with CGH, however, there is limited scientific evidence demonstrating meaningful impact for dry… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cervicogenic Headache
What is being tested?
Cervical-cranial dry needling, Orthopedic manual therapy and Thoracic Manipulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
5 Jul 2018to 10 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years or older
  • Meets the IHS criteria for CGH
  • Headache frequency of at least 1 per week over a period greater than 3 months.
  • Demonstrates segmental dysfunction with passive mobility testing.

Who cannot join

  • Patients whose headache experience is primarily of migraine origin. Tension-type headache, headache pain <2, contraindications to the interventions (malignancy, myelopathy, fracture, metabolic disease, rheumatoid arthritis, long-term corticosteroid use), headache presentation suggesting cervical arterial insufficiency, severe metal allergy, needle phobia, history of neck or thoracic spine surgery, Non-English speaking patients, therapist is unable to elicit the headache with passive accessory intervertebral movements (PAIVM), or pending litigation for neck pain and/or headache.

Trial locations and contacts

1 site in 1 country.

David Griswold, PhD contact

330-941-2419

dwgriswold@ysu.edu

United States1 site, 1 recruiting
  • Youngstown State University

    Youngstown, Ohio, 44406

    David W Griswold, PhD, DPT, 330-941-2419, dwgriswold@ysu.edu

    Recruiting

Other trials in United States

About this study

Official title: Comparing the Use of Cervical-Cranial Dry Needling With Orthopedic Manual Therapy to the Cervical Spine for Cervicogenic Headache: A Multi-center RCT With 1-Year Follow Up

Dry needling is a therapeutic modality used to treat a number of neuromusculoskeletal conditions. Practice trends suggest it is becoming widely used by Physical Therapists to help patients manage symptoms associated with CGH, however, there is limited scientific evidence demonstrating meaningful impact for dry needling for CGH. Manual therapy (thrust and non-thrust mobilizations) to the cervical spine are well researched and have an established treatment effect for managing symptoms related to CGH. The purpose of this study is to compare outcomes (1 week, 1 month, 3 months, 12 months) for patients with CGH treated with cervical-cranial dry needling or pragmatically applied orthopedic manual therapy to the cervical spine. In addition to either the cervical-cranial dry needling or manual therapy to the cervical spine, patients will also receive patient education, thoracic manipulation, and exercise.

Read the detailed description

The use of dry needling is becoming widely used by Physical Therapists in the United States for a number of neuromusculoskeletal conditions including cervicogenic headache (CGH). Dry needling is performed by taking a mono-filament needle and inserting it into symptomatic soft tissue. In this trial, the dry needling will be performed segmentally in the neck and along the patient's headache distribution pattern. Orthopedic manual therapy (OMT) may include both thrust and non-thrust techniques applied to a targeted spinal level and has a well-established treatment effect for patients with CGH. In this trial, the OMT will be applied pragmatically to the cervical spine at the most symptomatic level of the headache. Other interventions used in this trial will include patient education, thoracic manipulation and exercise.

Patients will be randomized to receive either dry needling or OMT 2x/week for 2 weeks and then 1-2x/week for 2 weeks totaling 6-8 visits over the course of 1 month. The 1 week and 1 month outcomes collected will be reported on separately from the 3 and 12 months.

Being tested
Cervical-cranial dry needling, Orthopedic manual therapy, Thoracic Manipulation, Exercise, Patient Education
Keywords
Neck pain, Headache, Dry needling, manual therapy
Medical subject headings
Post-Traumatic Headache, Neck Pain, Headache

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cervical-cranial dry needlingOther

    Segmental needling of the neck and needling in the patient's headache distribution. Peripherally sensitized areas of the neck may also be dry needled based on the findings of the clinical evaluation.

  • Orthopedic manual therapyOther

    Orthopedic Manual Therapy (OMT) that includes either mobilization or manipulation to the cervical spine applied pragmatically to the most symptomatic level.

  • Thoracic ManipulationOther

    Thoracic Manipulation (applied pragmatically) to the levels determined to be provocative or hypomobile.

  • ExerciseOther

    Clinicians select 1 active range of motion exercise for the cervical spine, deep cervical flexion endurance exercise, and 5 upper extremity exercises (from a set of 10). Additionally, patients will be assigned a headache management technique.

  • Patient EducationOther

    Patients will receive education regarding their headache condition, proper performance of their symptom management technique, posture.

Study groups in NCT03583190
Study groupRoleWhat they receive
Cervical-cranial dry needlingExperimentalPatients randomized to this arm will receive cervical-cranial dry needling, thoracic manipulation, and exercise.
Receives: Other: Cervical-cranial dry needling; Other: Thoracic Manipulation; Other: Exercise; Other: Patient Education
Orthopedic Manual TherapyActive comparatorPatients randomized to this arm will receive orthopedic manual therapy to cervical spine, thoracic manipulation, and exercise.
Receives: Other: Orthopedic manual therapy; Other: Thoracic Manipulation; Other: Exercise; Other: Patient Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in NPRS headache intensity

    Average and most intense in the last week will be recorded using a 0 (no headache) to 10 (most intense)

    Measured: Baseline, 1 week, 1 month, 3 months, 12 months.

Secondary outcomes (8)
  1. Change in disability using Neck Disability Index

    The NDI is a self-report measure of perceived disability comprised of ten questions using an ordinal scale from 0 to 5 for a maximum of 50 points.

    Measured: Baseline 1 week, 1 month, 3 months, 12 months

  2. Change in disability using Headache Disability Index (HDI)

    The HDI assesses "the burden of chronic headaches," using 25 items that ask about the perceived impact of headaches on emotional functioning and daily activities. Items were designed specifically to assess the concerns of individuals with recurrent headache disorders.

    Measured: Baseline, 1 week, 1 month, 3 months, 12 months

  3. Leeds Assessment of Neuropathic Signs and Symptoms (LANSS)

    Subjects identifying particular qualities about their pain (yes/no) that could suggest problems with how the nervous system is interpreting pain. There is a physical screening procedure involving a discriminate evaluation of different sensations (light touch, and sharp/dull) in an area of the subject's body (arm or leg) without pain compared to an area of their pain (neck or head). The questions and results from the physical testing are scored which can range from 0-24.

    Measured: Baseline

  4. Change in Medication intake

    Patients will identify the medications + dosage they have consumed to treat their headache in the past week.

    Measured: Baseline, 1 week, 1 month, 3 months, 12 months

  5. Patient Satisfaction

    Patient satisfaction will be assessed using the Patient Satisfaction Instrument (PSI) that measures several constructs related to clinical outcomes and patient care. The PSI consists of 12 questions rated using a scale, 1 (strongly disagree) to 5 (strongly agree).

    Measured: 1 month

  6. Health care utilization

    Healthcare utilization will be reported by subjects identifying on a form any provider they have seen for care of their headaches, treatments they have received, and cost for their headaches.

    Measured: 3 and 12 months

  7. SANE Percent Recovery

    Percent recovery will be measured using a global percentage of improvement is a measure of the patient's perception of the change in their condition.

    Measured: 1 month

  8. Change in current NPRS neck or headache intensity

    Current level of headache or neck pain on a scale ranging from 0 (no headache) to 10 (most intense)

    Measured: Baseline and Immediately post intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2018
  2. Study start5 Jul 2018
  3. Primary completion10 Oct 2025 (estimated)
  4. Study completion10 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03583190
Sponsor's protocol ID
0177-08
Status last verified
Nov 2023
First submitted
18 Jun 2018
Last updated
18 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sedighi A, Nakhostin Ansari N, Naghdi S. Comparison of acute effects of superficial and deep dry needling into trigger points of suboccipital and upper trapezius muscles in patients with cervicogenic headache. J Bodyw Mov Ther. 2017 Oct;21(4):810-814. doi: 10.1016/j.jbmt.2017.01.002. Epub 2017 Jan 6.

    PubMed 29037632
  • France S, Bown J, Nowosilskyj M, Mott M, Rand S, Walters J. Evidence for the use of dry needling and physiotherapy in the management of cervicogenic or tension-type headache: a systematic review. Cephalalgia. 2014 Oct;34(12):994-1003. doi: 10.1177/0333102414523847. Epub 2014 Mar 12.

    PubMed 24623124
  • Bond BM, Kinslow C. Improvement in clinical outcomes after dry needling in a patient with occipital neuralgia. J Can Chiropr Assoc. 2015 Jun;59(2):101-10.

    PubMed 26136602

Questions about this trial

What is this clinical trial studying?

A study testing Cervical-cranial dry needling, Orthopedic manual therapy and Thoracic Manipulation in people with Cervicogenic Headache, run by Youngstown State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact David Griswold, PhD (330-941-2419, dwgriswold@ysu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in NPRS headache intensity (time frame: Baseline, 1 week, 1 month, 3 months, 12 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03583190, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in